Although early studies in AML patients suggested that only CD34+CD38− cells retained AML-propagating properties [15, 16], more recent studies have revealed that cells outside this compartment may also have cancer propagating potential [17-20]. The gene discussed is CD34; the disease is acute myeloid leukemia.